Round out your CMHC educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies. There are no additional fees to attend once you have registered for CMHC West and meals or refreshments may be provided. Register for CMHC West today and attend these activities.
Non-CME Lunch Symposium · Friday, May 3, 2019 · 12:15pm – 1:30pm · AKIMEL BALLROOM
Expert Insights: Managing Cardiovascular Risk Based on the Landmark CV Outcomes Trial (REDUCE-IT™)
Faculty: Krishnaswami Vijayaraghavan, MD, President Innovative Cardiometabolic Center
Despite the benefits of LDL-C lowering, many patients on statin therapy with elevated triglycerides remain at risk for cardiovascular (CV) disease. In this presentation, Expert Insights: Managing Cardiovascular Risk Based on the Landmark CV Outcomes Trial (REDUCE-IT™), the results from the CV outcomes trial, REDUCE-IT™, will be reviewed. REDUCE-IT compared the number of major adverse CV events in 8179 patients with statin-controlled LDL-C, elevated triglycerides, and other CV risk factors including established CVD and diabetes.
Visit the Amarin booth for more information.